Drug shortage: Lisdexamfetamine Dimesylate Tablet, Chewable (VYVANSE, LISDEXAMFETAMINE DIMESYLATE)
FDA lists 18 presentations as Current. Availability: Available (18). Companies: Takeda Pharmaceuticals USA Inc., Sun Pharmaceutical Industries, Inc., Novadoz Pharmaceuticals LLC.
- Published by source
- 2023-07-14
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Takeda Pharmaceuticals USA Inc.
- Products
- Lisdexamfetamine Dimesylate Tablet, Chewable VYVANSE LISDEXAMFETAMINE DIMESYLATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Available
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-07-14
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #916 | new | 2026-10-22 | 809d377b9af0…19bd8d | f65fb2a8752c…634719 |
Chain head: #1076 8ad5adc30b9b…88ce20